Ukr.Biochem.J. 2022; Volume 94, Issue 1, Jan-Feb, pp. 114-119


Ischemia modified albumin and thiol/disulfide balance in patients with Hashimoto’s thyroiditis

E. Avci1*, A. Karabulut2, G. Alp Avci3, C. Bilgi4

1University of Health Sciences, Gülhane Faculty of Pharmacy, Department of Biochemistry, Ankara, Turkey;
2Hitit University, Faculty of Medicine, Department of InternalMedicine, Corum, Turkey;
3University of Health Sciences, Gülhane Faculty of Dentistry, Department of Basic Medical Sciences, Ankara, Turkey;
4Yüksek İhtisas University, Faculty of Medicine, Department of Medical Biochemistry, Ankara, Turkey;

Received: 01 November 2021; Accepted: 21 January 2022

Hashimoto thyroiditis is a common cause of goiter and acquired hypothyroidism in individuals residing in areas of no iodine deficiency. The fact that the structure of serum albumin exhibits changes in ischemic conditions has paved the way for the discovery of a new serum cardiac ischemia marker, Ischemia Modified Albumin. The other one, thiol/disulphide homeostasis, plays an important part in antioxidative protection, detoxification, cell growth, and apoptosis. In this study, we aimed to investigate both the relationship between Thiol/Disulphide homeostasis and Ischemia Modified Albumin in patients diagnosed with Hashimoto’s Thyroiditis. A total of 70 Hashimoto’’s thyroiditis patients and 50 healthy ones were included in this study. Age, gender, thyroid-stimulating hormone (TSH), anti-thyroid peroxidase (TPO), anti-thyroglobulin (TG) levels were recorded. Ischemia Modified Albumin and thiol-disulphid homeostasis parameters were measured through automated spectrophotometric methods. The ages of individuals included in the study ranged from 35 to 58 years. The native thiol/total thiol were found to be significantly lower in Hashimoto patients when compared to those enrolled in the control group (P < 0.05), whereas the Ischemia Modified Albumin, disulphide, native thiol, total thiol, disulphide/native thiol, and disulphide/total thiol were found to be significantly higher in Hashimoto patients when compared to those in the control (P < 0.05). Increased Ischemia Modified Albumin, native and total thiol, and disulphide levels are related to increased oxidative stress. Although Ischemia Modified Albumin and Thiol-disulphide defense are important oxidative indicators in Hashimoto’s Thyroiditis, many determinants are known to be involved in this process.

Keywords: , ,


  1. Salmaso C, Bagnasco M, Pesce G, Montagna P, Brizzolara R, Altrinetti V, Richiusa P, Galluzzo A, Giordano C. Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto’s thyroiditis and Graves’ disease. Ann N Y Acad Sci. 2002;966:496-501. PubMed, CrossRef
  2. Mazziotti G, Sorvillo F, Iorio S, Carbone A, Romeo A, Piscopo M, Capuano S, Capuano E, Amato G, Carella C. Grey-scale analysis allows a quantitative evaluation of thyroid echogenicity in the patients with Hashimoto’s thyroiditis. Clin Endocrinol (Oxf). 2003;59(2):223-229. PubMed, CrossRef
  3. Rose NR, Bonita R, Burek CL. Iodine: an environmental trigger of thyroiditis. Autoimmun Rev. 2002;1(1-2):97-103. PubMed, CrossRef
  4. Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol. 2003;148(1):1-9. PubMed, CrossRef
  5. Negro R. Selenium and thyroid autoimmunity. Biologics. 2008;2(2):265-273. PubMed, PubMedCentral, CrossRef
  6. Syburra C, Passi S. Oxidative stress in patients with multiple sclerosis. Ukr Biokhim Zhurn. 1999;71(3):112-115. PubMed
  7. Toy H, Camuzcuoglu H, Camuzcuoglu A, Celik H, Aksoy N. Decreased serum prolidase activity and increased oxidative stress in early pregnancy loss. Gynecol Obstet Invest. 2010;69(2):122-127. PubMed, CrossRef
  8. Verma P, Bhattacharya SN, Banerjee BD, Khanna N. Oxidative stress and leukocyte migration inhibition response in cutaneous adverse drug reactions. Indian J Dermatol Venereol Leprol. 2012;78(5):664. PubMed, CrossRef
  9. Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes – review and clinical implications. Clin Chem Lab Med. 2011;49(2):177-184. PubMed, CrossRef
  10. Cakir M, Karahan SC, Mentese A, Sag E, Cobanoglu U, Polat TB, Erduran E. Ischemia-modified albumin levels in children with chronic liver disease. Gut Liver. 2012;6(1):92-97. PubMed, PubMedCentral, CrossRef
  11. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47(18):326-332. PubMed, CrossRef
  12. Ates I, Kaplan M, Inan B, Alisik M, Erel O, Yilmaz N, Guler S. How does thiol/disulfide homeostasis change in prediabetic patients? Diabetes Res Clin Pract. 2015;110(2):166-171. PubMed, CrossRef
  13. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med. 2000;19(4):311-315. PubMed, CrossRef
  14. Mertoglu C, Gunay M, Gurel A, Gungor M, Gul V. Ischemic modified albumin increases in acute kidney injury. Revista Romana de Medicina de Laborator. 2018;26(1): 37-43. CrossRef
  15. Solakhan M, Cicek H, Orhan N, Yildirim M. Role of native Thiol, total Thiol and dynamic Disulphide in diagnosis of patient with prostate cancer and prostatitis. Int Braz J Urol. 2019;45(3):495-502. PubMed, PubMedCentral, CrossRef
  16. Kaman A, Aydın Teke T, Gayretli Aydın ZG, Karacan Küçükali G, Neşelioğlu S, Erel Ö, Tanır G. Dynamic thiol/disulphide homeostasis and pathogenesis of Kawasaki disease. Pediatr Int. 2019;61(9):913-918. PubMed, PubMedCentral, CrossRef
  17. Arhan E, Kurt ANC, Neselioglu S, Yerel O, Uçar HK, Aydin K, Serdaroglu A. Effects of antiepileptic drugs on dynamic thiol/disulphide homeostasis in children with idiopathic epilepsy. Seizure. 2019;65:89-93. PubMed, CrossRef
  18. Turedi S, Cinar O, Kaldirim U, Mentese A, Tatli O, Cevik E, Tuncer SK, Gunduz A, Yamanel L, Karahan SC. Ischemia-modified albumin levels in carbon monoxide poisoning. Am J Emerg Med. 2011;29(6):675-681. PubMed, CrossRef
  19. Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355-382. PubMed, PubMedCentral, CrossRef
  20. Gu C, Jun JC. Does Hypoxia Decrease the Metabolic Rate? Front Endocrinol (Lausanne). 2018;9:668. PubMed, PubMedCentral, CrossRef
  21. Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J. 2016;15(1):71. PubMed, PubMedCentral, CrossRef
  22. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010;4(8):118-126. PubMed, PubMedCentral, CrossRef
  23. Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine. 2004;24(1):1-13. PubMed, CrossRef
  24. Lippi G, Montagnana M, Guidi GC. Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? Int J Cardiol. 2006;108(3):410-411. PubMed, CrossRef
  25. Ma SG, Yang LX, Bai F, Xu W, Hong B. Ischemia-modified albumin in patients with hyperthyroidism and hypothyroidism. Eur J Intern Med. 2012;23(6):e136-e140. PubMed, CrossRef
  26. Oran I, Oran B. Ischemia-Modified Albumin as a Marker of Acute Coronary Syndrome: The Case for Revising the Concept of “N-Terminal Modification” to “Fatty Acid Occupation” of Albumin. Dis Markers. 2017;2017:5692583. PubMed, PubMedCentral, CrossRef
  27. Reddy SV, Suchitra MM, Pradeep V, Alok S, Suresh V, Bitla AR, Srinivasa Rao PVLN. Ischemia-modified albumin levels in overt and subclinical hypothyroidism. J Endocrinol Invest. 2015;38(8):885-890. PubMed, CrossRef
  28. Kundi H, Ates I, Kiziltunc E, Cetin M, Cicekcioglu H, Neselioglu S, Erel O, Ornek E. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med. 2015;33(11):1567-1571. PubMed, CrossRef
  29. Yuksel M, Ates I, Kaplan M, Alışık M, Erel Ö, Saygılı F, Kayaçetin E. The dynamic thiol/disulphide homeostasis in inflammatory bowel disease and its relation with disease activity and pathogenesis. Int J Colorectal Dis. 2016;31(6):1229-1231. PubMed, PubMedCentral, CrossRef
  30. Ates I, Kaplan M, Yuksel M, Mese D, Alisik M, Erel Ö, Yilmaz N, Guler S. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine. 2016;51(1):47-51. PubMed, CrossRef
  31. Or KA, Dağdeviren M, Akkan T, Ateş İ, Neşelioğlu S, Erel Ö, Altay M. Dynamic thiol/disulfide homeostasis and oxidant status in patients with hypoparathyroidism. J Med Biochem. 20203;39(2):231-239. PubMed, PubMedCentral, CrossRef
  32. Mengen E, Uçaktürk SA, Kocaay P , Kaymaz Ö, Neşelioğlu S, Erel Ö. The Significance of Thiol/Disulfide Homeostasis and Ischemia-modified Albumin Levels in Assessing Oxidative Stress in Obese Children and Adolescents. J Clin Res Pediatr Endocrinol. 2020;12(1):45-54. PubMed, PubMedCentral, CrossRef
  33. Kar YD, Özdemir ZC, Bör Ö. Thiol / disulfide balance and oxidative stress parameters in pediatric patients diagnosed with acute and chronic idiopathic thrombocytopenic purpura. Turk J Pediatr. 2021;63(6):962-969. PubMed, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.